Updated Jul 16, 2026
Booth Andrew has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $146K.
Andrew Booth is the Chief Financial Officer at AbCellera Biologics Inc., a biotechnology company specializing in antibody discovery and development. He has a background in finance and management, contributing to the company's strategic financial planning and operations.
| Role | Chief Financial Officer |
|---|---|
| Notability | 75/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-03 | ABCL | AbCellera Biologics Inc. | M — Option exercise | 250.0K | $0.19 | $48K |
| 2026-02-27 | ABCL | AbCellera Biologics Inc. | P — Open-market purchase | 42.6K | $3.42 | $146K |
Andrew Booth is the Chief Financial Officer at AbCellera Biologics Inc., a biotechnology company specializing in antibody discovery and development. He has a background in finance and management, contributing to the company's strategic financial planning and operations.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($146K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Booth Andrew profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.